Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiation. [electronic resource]
Producer: 20140121Description: 1593-8 p. digitalISSN:- 1916-7075
- Administration, Oral
- Aged
- Aged, 80 and over
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Cardiovascular Diseases -- prevention & control
- Cohort Studies
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Angiopathies -- prevention & control
- Drug Therapy, Combination
- Drug Utilization -- statistics & numerical data
- Female
- Guideline Adherence
- Humans
- Hypoglycemic Agents -- therapeutic use
- Logistic Models
- Male
- Metformin -- therapeutic use
- Multivariate Analysis
- Quebec
- Rural Population -- statistics & numerical data
- Sulfonylurea Compounds -- therapeutic use
- Urban Population -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.